About FDA

FDA Drug Topics: FDA Adverse Events Reporting System (FAERS) Public Dashboard - January 30, 2018

FDA’s Division of Drug Information in the Center for Drug Evaluation and Research (CDER) is excited to present a series of educational webinars targeting the needs of all health care professionals and students, including physicians, physician assistants, nurses, pharmacists, and pharmacy technicians. Interact with FDA staff from a variety of divisions and learn more about the FDA and drug regulation!

On Tuesday, January 30, 2018, CDER's Office of Communication, Division of Drug Information (DDI) hosted a webinar titled: FDA Drug Topics: FDA Adverse Events Reporting System (FAERS) Public Dashboard. This webinar provided an overview of the FAERS Public Dashboard, a highly interactive web-based tool that allows for the querying of FAERS data in a user-friendly fashion. The intention of this tool is to expand access of FAERS data to the general public to search for information related to human adverse events reported to the FDA by the pharmaceutical industry, healthcare providers and consumers. FDA anticipates that this increased transparency will help to spur the submission of more detailed and complete reports from consumers, health care providers and other members of the public.

View Presentation: https://collaboration.fda.gov/p3o805b1t7w/

Download Presentation Slides: FDA Adverse Events Reporting System (FAERS) Public Dashboard (PDF - 4.13MB)

Activity Outline and Continuing Education Information: FDA Adverse Events Reporting System (FAERS) Public Dashboard (PDF - 54KB)

If you have never attended an Adobe Connect meeting before:

Adobe, the Adobe logo, Acrobat and Adobe Connect are either registered trademarks or trademarks of Adobe Systems Incorporated in the United States and/or other countries.

Page Last Updated: 02/21/2018
Note: If you need help accessing information in different file formats, see Instructions for Downloading Viewers and Players.
Language Assistance Available: Español | 繁體中文 | Tiếng Việt | 한국어 | Tagalog | Русский | العربية | Kreyòl Ayisyen | Français | Polski | Português | Italiano | Deutsch | 日本語 | فارسی | English